Hansen acquires HMO manufacturer Jennewein
Hansen recently announced that it has signed an agreement to acquire HMO producer Jennewein Biotechnologie for EUR 310 million, officially entering the human milk oligosaccharide (HMO) market.
It is reported that Hansen will acquire all shares of Jennewein through the transaction, which is in line with Hansen’s 2025 strategy to expand and strengthen its microbial and fermentation technology platform through acquisitions.
Hansen pointed out that functional ingredients such as HMO and probiotics are leading the infant formula optimization market.
It is reported that the transaction will be completed this month, and HMO will operate independently as a business under the health and nutrition division of Hansen. After the transaction is completed, Hansen will invest 200 million euros in production assets, including a parcel plant, to increase HMO production capacity by 2025.
You May Interested In
SS-31 Cosmetic peptides, discounted price improving cognitive impairment factory supply
$8E+1/UNIT FOB
2026-09-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Chr. Hansen considers selling natural pigment business
-
Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical Agree in Principle to Establish New Joint Venture to Restructure Ethylene Production in Western Japan
-
Semcorp's Hungarian Factory Ordered to Shut Down Over Pollution
-
Saudi Arabia Flips the Switch on Jafurah: World’s Largest Non-U.S. Shale Gas Field Begins Production
-
India Loosens Import Leash: Scraps Quality Control Orders for 7 Key Petrochemicals to Revive Manufacturing
-
Dow’s “Double Salvo”: Behind the €150/ton Hike, Europe’s Chemical Industry Is Being Strangled by a “Cost Noose”
-
Clariant Names Marcelo Lu as Heir Apparent in High-Stakes Leadership Handover for Care Chemicals
-
5%–10% Is Just the Surface: Behind Dow’s Greater China Price Letter Lies a Global Repricing of Silicones
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Dawn Seizes Strategic Control of EPDM Supply Chain with Acquisition of Ningbo SK—A Bold Leap Toward Global Elasticity
Recommend Reading
-
![Syngenta Gets a New Boss]()
Syngenta Gets a New Boss
-
![Bayer Wins Big on Roundup]()
Bayer Wins Big on Roundup
-
![Growing Pains, But the Roots Are Strong: Corteva Narrows Losses Amid Sales Surge in Q3 2025]()
Growing Pains, But the Roots Are Strong: Corteva Narrows Losses Amid Sales Surge in Q3 2025
-
![From the Brink to the Bend: Bayer’s Q3 2025 Shows Dramatic Loss Reduction—but Crop Science Still Bleeds]()
From the Brink to the Bend: Bayer’s Q3 2025 Shows Dramatic Loss Reduction—but Crop Science Still Bleeds
-
![Profit Soars While Sales Dip: Syngenta Group Defies Headwinds with 28% EBITDA Surge in Q3 2025]()
Profit Soars While Sales Dip: Syngenta Group Defies Headwinds with 28% EBITDA Surge in Q3 2025
-
![Premium Global Chemical Sourcing Requests (26 - 30 Jan, 2026)]()
Premium Global Chemical Sourcing Requests (26 - 30 Jan, 2026)
-
![Crude oil remains in negative territory, another round of retail fuel price cuts in China]()
Crude oil remains in negative territory, another round of retail fuel price cuts in China
-
![FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?]()
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
![India Unleashes a Triple-Action Defender: Parijat Introduces NILANIX SC into the Rice Battlefront]()
India Unleashes a Triple-Action Defender: Parijat Introduces NILANIX SC into the Rice Battlefront
-
![France’s Vineyards Find a New Shield: Eden’s Mevalone Enters the Frontline of a Changing Fungicide Era]()
France’s Vineyards Find a New Shield: Eden’s Mevalone Enters the Frontline of a Changing Fungicide Era
